Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

News: Gene expression signatures of... (NIH Research Matters) - Behind the headlines

In the news

Media coverage of health and science topics

NIH Research Matters May 21, 2019

Gene expression signatures of Alzheimer’s disease

A resource of gene expression patterns from the brain cells of people who had Alzheimer’s disease may enable advances in understanding how the disease develops.

Read more at NIH Research Matters

Behind the headlines

Research findings and data from the National Library of Medicine

PubMed articles

Nature MAY 1, 2019

Single-cell transcriptomic analysis of Alzheimer's disease

H Mathys et al

Alzheimer's disease is a pervasive neurodegenerative disorder, the molecular complexity of which remains poorly understood. Here, we analysed 80,660 single-nucleus transc …

Related content

Similar articles

Reviews

People also viewed

Also of interest

Additional recent and related news

The Scientist JULY 6, 2018

Natural Killer Cells Prove Effective as a CAR Therapy in Mice

Stem-cell–derived natural killer cells engineered in a similar way to CAR-T cells may pave the way to “off the shelf” cancer therapies that aren’t patient-specific.

The Scientist FEBRUARY 4, 2019

New Map Shows Brain Changes Associated with Alzheimer’s

The protein expression data, which are freely available online, could help identify new drug targets for the disease.

NIH Research Matters FEBRUARY 4, 2020

Predicting Alzheimer’s disease progression

A study suggested that PET imaging of tau tangles in the brain could be a way to track development of Alzheimer’s disease, predict loss of brain tissue, and assess new treatments.

NIH Research Matters OCTOBER 2, 2018

Exercise and new nerve cell growth in Alzheimer’s disease

In a mouse model of Alzheimer’s disease, access to exercise stimulated the growth of new nerve cells in the brain and reduced memory problems. The findings pave the way for studies in people.

NIH Research Matters AUGUST 18, 2020

Blood tests show promise for early Alzheimer’s diagnosis

Blood levels of a protein called ptau217 were associated with damage to the brain caused by Alzheimer’s disease, and may one day help diagnose disease before symptoms appear.